Tag: biotechnology
-
Sangamo, Pfizer Partner on ALS Gene Therapy
Drug maker Pfizer Inc. is licensing and collaborating on a gene therapy technology from Sangamo Therapeutics Inc. to treat amyotrophic lateral sclerosis, or ALS, and a related neurodegenerative disease.
-
RNA Therapies Start-Up Raises $55.3M in Early Funds
A start-up company creating treatments for inherited diseases that target faulty RNA transcribed from genetic codes is raising $55.3 million in its first venture funding round.
-
NIH Grant Funds Synthetic Peptide for Severe Asthma
A synthetic peptide, a short chain of amino acids, is being developed as a treatment for severe cases of asthma that do not respond to conventional drugs.
-
Techniques Devised to Speed-Up Plant Breeding
Plant scientists in Australia and the U.K. developed a process that sharply cuts the amount of time needed to produce new breeds of plant crops including commercial varieties of wheat.
-
Cell Engineering Company Launches, Raises $4.7 Million
A company designing biological circuits with techniques derived from computer-assisted design like those used in semiconductors is starting up in Cambridge, Massachusetts.
-
FDA Approves Gene Therapy for Inherited Vision Loss
A therapy using transfers of healthy genes to treat a rare form of inherited vision loss was approved today by the U.S. Food and Drug Administration.
-
Biotechs Partner on HPV Cancer Immunotherapies
Biotechnology companies in the U.S. and the Netherlands are collaborating on treatments for cancers caused by a type of human papillomavirus, or HPV.
-
FDA Fast-Tracks Heart Failure Gene Therapy
A biotechnology company developing transfers of healthy genes to treat chronic diseases is receiving an accelerated review of its heart failure therapy from the U.S. Food and Drug Administration.
-
CAR T-Cells Shown Effective in Long-Term Studies
Results from two clinical studies of engineered immune system cells show patients continue to respond their treatments after 6 months or more.
-
PTSD Drug Trial Begins, Gets Fast-Track Status
An experimental drug that aims to keep nerve cells flexible is beginning an early-stage clinical trial as a treatment for post-traumatic stress disorder, or PTSD.